|
1
|
Chen X, Bahrami A, Pappo A, Easton J,
Dalton J, Hedlund E, Ellison D, Shurtleff S, Wu G, Wei L, et al:
Recurrent somatic structural variations contribute to tumorigenesis
in pediatric osteosarcoma. Cell Rep. 7:104–112. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Mirabello L, Troisi RJ and Savage SA:
Osteosarcoma incidence and survival rates from 1973 to 2004.
Cancer. 115:1531–1543. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Anninga JK, Gelderblom H, Fiocco M, Kroep
JR, Taminiau AH, Hogendoorn PC and Egeler RM: Chemotherapeutic
adjuvant treatment for osteosarcoma: where do we stand? Eur J
Cancer. 47:2431–2145. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Clark JC, Dass CR and Choong PF: A review
of clinical and molecular prognostic factors in osteosarcoma. J
Cancer Res Clin Oncol. 134:281–297. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Abu-Odeh M, Salah Z, Herbel C, Hofmann TG
and Aqeilan RI: Wwox, the common fragile site FRA16D gene product,
regulates ATM activation and the DNA damage response. Proc Natl
Acad Sci USA. 111:E4716–E4725. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Chang NS, Pratt N, Heath J, Schultz L,
Sleve D, Carey GB and Zevotek N: Hyaluronidase induction of a WW
domain-containing oxidoreductasethat enhances tumor necrosis factor
cytotoxicity. J Biol Chem. 276:3361–70. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Yu K, Fan J, Ding X, Li C, Wang J, Xiang Y
and Wang QS: Association study of a functional copy number
variation in the Wwox gene with risk of gliomas among Chinese
people. Int J Cancer. 135:1687–1691. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang D, Qiu F, Yang L, Li Y, Cheng M,
Wang H, Ma G, Wang Y, Hu M, Ji W, et al: The polymorphisms and
haplotypes of Wwox gene are associated with the risk of lung cancer
in southern and eastern Chinese populations. Mol Carcinog.
52:E19–E27. 2013. View
Article : Google Scholar : PubMed/NCBI
|
|
9
|
Cancemi L, Romei C, Bertocchi S, Tarrini
G, Spitaleri I, Cipollini M, Landi D, Garritano S, Pellegrini G,
Cristaudo A, et al: Evidences that the polymorphism Pro-282-Ala
within the tumor suppressor gene Wwox is a new risk factor for
differentiated thyroid carcinoma. Int J Cancer. 129:2816–2824.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Wu Z, Ma C, Shan Z, Ju Y, Li S and Zhao Q:
Histone deacetylase inhibitors suppress the growth of human
osteosarcomas in vitro and in vivo. J Buon. 18:1032–1037.
2013.PubMed/NCBI
|
|
11
|
Levine AJ and Oren M: The first 30 years
of p53: Growing ever more complex. Nat Rev Cancer. 9:749–757. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li D and Marchenko ND: ErbB2 inhibition by
lapatinib promotes degradation of mutant p53 protein in cancer
cells. Oncotarget. 8:5823–5833. 2017.PubMed/NCBI
|
|
13
|
Chen W, Cooper TK, Zahnow CA, Overholtzer
M, Zhao Z, Ladanyi M, Karp JE, Gokgoz N, Wunder JS, Andrulis IL, et
al: Epigenetic and geneticloss of HIC1 function accentuates the
role of p53 in tumorgenes. Cancer Cell. 6:387–398. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Chang NS, Hsu LJ, Lin YS, Lai FJ and Sheu
HM: WW domain-containingoxidoreductase: A candidate tumor
suppressor. Trends Mol Med. 13:12–22. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Del MS and Aqeilan RI: Tumor suppressor
Wwox inhibits osteosarcoma metastasis by modulating RUNX2 function.
Sci Rep. 5:129592015. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Abdeen SK, Del MS, Hussain S, Abu-Remaileh
M, Salah Z, Hagan J, Rawahneh M, Pu XA, Russell S, Stein JL, et al:
Conditional inactivation of the mouse Wwox tumor suppressor gene
recapitulates the null phenotype. J Cell Physiol. 228:1377–1382.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Mercer J, Mahmoudi M and Bennett M: DNA
damage, p53, apoptosis and vascular disease. Mutat Res. 621:75–86.
2007. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Subramanian M, Jones MF and Lal A: Long
non-codingRNAs embedded in the Rb and p53 pathways. Cancers
(Basel). 5:1655–1675. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Bargonetti J and Manfred IJJ: Multiple
roles of the tumor suppressor p53. Curr Opin Oncol. 14:86–91. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Mardanpour K, Rahbar M and Mardanpour S:
Coexistence of HER2, Ki67 and p53 in Osteosarcoma: A strong
prognostic factor. N Am J Med Sci. 8:210–214. 2016. View Article : Google Scholar : PubMed/NCBI
|
